These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2189903)

  • 21. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A one year study of single administration of nilvadipine. Results of the effectiveness and long-term tolerance in hypertension].
    Faust G
    Fortschr Med; 1993 Apr; 111(11):188-92. PubMed ID: 8508996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.
    Glasser SP; Chrysant SG; Graves J; Rofman B; Koehn DK
    Am J Hypertens; 1989 Mar; 2(3 Pt 1):154-7. PubMed ID: 2522008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the acute hypotensive effects of two different doses of nifedipine.
    Maharaj B; van der Byl K
    Am Heart J; 1992 Sep; 124(3):720-5. PubMed ID: 1514500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
    Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
    Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once daily amlodipine in the treatment of mild to moderate hypertension.
    Webster J; Robb OJ; Jeffers TA; Scott AK; Petrie JC; Towler HM
    Br J Clin Pharmacol; 1987 Dec; 24(6):713-9. PubMed ID: 2964253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
    Wu WH; Henderson BM; Lanc R; Garnes D; Yacobi A; Silber BM
    Drug Metab Dispos; 1988; 16(2):222-7. PubMed ID: 2898337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study.
    Shimamoto K; Hasebe N; Ito S; Kario K; Kimura K; Dohi Y; Kawano Y; Rakugi H; Horiuchi M; Imaizumi T; Ohya Y
    Hypertens Res; 2014 Jan; 37(1):69-75. PubMed ID: 23945965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
    Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
    PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension.
    Beer N; Gallegos I; Cohen A; Klein N; Sonnenblick E; Frishman W
    Chest; 1981 May; 79(5):571-4. PubMed ID: 7226935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amlodipine: a double-blind evaluation of the dose-response relationship in mild to moderate hypertension.
    Frick MH; McGibney D; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S76-8. PubMed ID: 2467135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of regression of vascular structural changes and its relation to cytosolic free calcium in hypertensives after nilvadipine treatment.
    Ueno H; Takata M; Oh-hashi S; Tomoda F; Yasumoto K; Inoue H
    J Hum Hypertens; 1995 Sep; 9(9):735-9. PubMed ID: 8551487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipine.
    Cheung WK; Sia LL; Woodward DL; Graveline JF; Desjardins RE; Yacobi A; Silber BM
    J Clin Pharmacol; 1988 Nov; 28(11):1001-7. PubMed ID: 3243913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
    Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
    Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats.
    Takakura S; Furuichi Y; Yamamoto T; Ogawa T; Satoh H; Mori J
    Stroke; 1994 Mar; 25(3):677-82; discussion 682-3. PubMed ID: 8128525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
    Graney WF
    Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifedipine-retard versus nifedipine-capsules for the therapy of hypertensive crisis in black patients.
    Damasceno A; Sevene E; Patel S; Polónia J
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):165-9. PubMed ID: 9456291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.